Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases

NCT00278564 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped high relapse rate

Conditions

MYOPATHY

Interventions

BIOLOGICAL: Hematopoietic stem cell transplantation
DRUG: Cyclophosphamide
DRUG: Mesna
DRUG: ATG(rabbit)
DRUG: Methylprednisolone
DRUG: G-CSF
DRUG: Rituxan

Sponsor

Northwestern University